Rapid-Onset Opioid vs Neuromuscular Blocker for Rapid Sequence Intubation, 180-Day Outcomes in COVID-19 in REMAP-CAP, Recommendations for Antiretrovirals for Treatment and Prevention of HIV, and more

JAMA Editor’s Summary

Rapid-Onset Opioid vs Neuromuscular Blocker for Rapid Sequence Intubation, 180-Day Outcomes in COVID-19 in REMAP-CAP, Recommendations for Antiretrovirals for Treatment and Prevention of HIV, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 3, 2023, issue. Related Content:

January 3, 2023

Listen on your favorite player Take me to this show’s page

Newer →

Catheter Ablation Techniques for Persistent Atrial Fibrillation, Medical Device Recalls, Review of Autism Spectrum Disorder, and more

← Older

Labor Unionization Among US Health Care Workers, Association of Family Income With Children’s Health, Review of Anxiety Disorders, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Rapid-Onset Opioid vs Neuromuscular Blocker for Rapid Sequence Intubation, 180-Day Outcomes in COVID-19 in REMAP-CAP, Recommendations for Antiretrovirals for Treatment and Prevention of HIV, and more

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief of JAMA, the Journal of the American Medical Association, for the January 3, 2023, issue. Related Content:

Audio Highlights

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

00:00

00:00